Elixir Drugs Private Limited - Company Profile

It is a healthcare private limited company based in Meerut, Uttar Pradesh, India, established in 2008.
2008 Meerut, Uttar Pradesh, India Active
Last Updated:
Access Report
About Elixir Drugs Private Limited

Elixir Drugs Private Limited, a active private limited company, was established on 08 April 2008 in Meerut, Uttar Pradesh, India. Engaging in ayurvedic products & services within the trade sector, it holds CIN: U24233UP2008PTC034961. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Anupma Saxena (Director), Sanjay Saxena (Director). Past directors included Savita Tyagi, Girish Tyagi, Hemant Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 138, New Hanuman Puri Suraj Kund Road, Meerut, Uttar Pradesh, 250002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233UP2008PTC034961

  • Registration Number

    034961

  • Incorporation Date

    08 April 2008

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -4.39%
  • Profit Growth **** -5.08%
  • Ebitda **** 23.58%
  • Net Worth 6.23%
  • Total Assets **** 5.64%
Company report

Elixir Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elixir Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elixir Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Anupma Saxena Director 01 Nov 2011 Current
Sanjay Saxena Director 08 Apr 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Sep 2013 Past
Pramod Abcsdd Director 13 Mar 2010 Past
Pramod Abcsdd Director 31 Oct 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elixir Drugs.

Elixir Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.39% decrease. The company also saw a slight decrease in profitability, with a 5.08% decrease in profit. The company's net worth moved up by a moderate rise of 6.23%.

Elixir Drugs revenue growth over time
Elixir Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -4.39%
*******
*******
*******
*******
Revenue from Operations
*******
 -4.39%
*******
*******
*******
*******
Total Assets
*******
 5.64%
*******
*******
*******
*******
Profit or Loss
*******
 -5.08%
*******
*******
*******
*******
Net Worth
*******
 6.23%
*******
*******
*******
*******
EBITDA
*******
 23.58%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elixir Drugs?

Unlock access to Elixir Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Elixir Drugs?

Unlock and access historical data on people associated with Elixir Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elixir Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elixir Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Elixir Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Elixir Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Anupma Saxena was appointed as a Director was appointed as a Director on 01 Nov 2011 & has been associated with this company since 14 years 3 months . was completed.

  • Director Appointment

    Progress on Sanjay Saxena was appointed as a Director was appointed as a Director on 08 Apr 2008 & has been associated with this company since 17 years 10 months . was documented.

  • Company Incorporation

    Progress on Elixir Drugs Private Limited was registered on 08 Apr 2008 with Roc Kanpur & aged 17 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elixir Drugs Private Limited?

The CIN of Elixir Drugs Private Limited is U24233UP2008PTC034961.

Where is Elixir Drugs Private Limited headquartered?

Elixir Drugs Private Limited is headquartered at 138, New Hanuman Puri Suraj Kund Road, Meerut, Uttar Pradesh, 250002.

When was Elixir Drugs Private Limited incorporated?

Elixir Drugs Private Limited was incorporated on 08 April 2008.

Who are the current directors of Elixir Drugs Private Limited?

The current directors of Elixir Drugs Private Limited are

What is the primary industry of Elixir Drugs Private Limited?

The primary industry of Elixir Drugs Private Limited is Trade.

Is Elixir Drugs Private Limited a listed company?

Elixir Drugs Private Limited is unlisted.

What is the capital structure of Elixir Drugs Private Limited?

The authorized capital of Elixir Drugs Private Limited is ₹0.30 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Elixir Drugs Private Limited?

The compliance status of Elixir Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available